Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Horizons Psychedelic Stock Index ETF HPSYF

Consumer Cyclical
PSYK seeks to replicate, to the extent possible and net of expenses, the performance of a market index that is designed to provide exposure to the performance of a basket of North American publicly-listed life sciences companies having significant business activities in, or significant exposure to, the psychedelics industry. Currently, the ETF seeks to replicate the performance of the North American Psychedelics Index (the Underlying Index, Bloomberg ticker: HPSYKTR), net of expenses. The ETF will not seek to hedge any foreign currency exposure To achieve the ETFs investment objective, the ETF invests and holds equity securities of the Constituent Issuers in substantially the same proportion as the current Underlying Index. To the extent permitted, the ETF will generally be fully invested in or exposed to the Underlying Index at all times and will have substantial exposure to the North American psychedelics industry.


GREY:HPSYF - Post by User

Horizons Psychedelic Stock Index ETF
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(273)
•••
Post by partystockeron Dec 21, 2021 4:18pm
85 Views
Post# 34252163

Keeping an eye on upcoming ipo's in the psychedelic market

Keeping an eye on upcoming ipo's in the psychedelic market

With the Horizons Psychedelic ETF $HPSYF seeing some huge movement today (+27%) I’m keeping a close eye on some awaiting IPO’s in the industry. 


One of the Canadian players I’m keeping an eye on right now is the psychedelic fund Origin Therapeutics. Origin Therapeutics is supposedly expected to announce its IPO before the end of the quarter under the ticker $ORIG. 


Unlike most funds, $ORIG offers exposure to a unique blend of both public and private companies in the therapeutic psychedelics space. This gives investors early-access exposure to some of the biggest growth opportunities in the industry. 


I’m looking forward to some announcements from Origin regarding IPO, as now is a better time than ever if the industry starts to see a recovery.

 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities